Kaiser Permanente Washington
Seattle, Washington, United States
Doctor in Seattle, Washington
125 16th Ave E, Seattle, WA 98112
About Kaiser Permanente Washington
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
83
SWOG Cancer Research Network
21
Alliance for Clinical Trials in Oncology
18
Kaiser Permanente
6
ECOG-ACRIN Cancer Research Group
5
Gynecologic Oncology Group
5
Children's Oncology Group
3
GOG Foundation
3
Bayer
1
Fred Hutchinson Cancer Center
1
Member Companies of the Opioid PMR Consortium
1
Clinical Trials at Kaiser Permanente Washington
During the past decade, Kaiser Permanente Washington conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 75 clinical trials were completed, i.e. on
average, 98.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 48 clinical trials were completed. i.e. 1600%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
2007-09-14
2017-03-21
Completed
361
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaiser Permanente Washington" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 21 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "Kaiser Permanente" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 6 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Washington"
#1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 30 different institutions and companies that were
collaborators in the rest 31 trials.
Clinical Trials Conditions at Kaiser Permanente Washington
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Washington" are
"Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials), "Recurrent Primary Peritoneal Carcinoma" (7 trials) and "Recurrent Squamous Cell Lung Carcinoma" (7 trials). Many other conditions were trialed in "Kaiser Permanente Washington" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente Washington
Most popular intervention types in "Kaiser Permanente Washington" are "Drug" (116 trials), "Other" (107 trials), "Biological" (61 trials), "Procedure" (31 trials) and "Radiation" (17 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (69 trials), "Quality-of-Life Assessment" (37 trials), "Paclitaxel" (19 trials), "Carboplatin" (17 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente Washington
The vast majority of trials in "Kaiser Permanente Washington" are
117 trials for "All" genders and 34 trials for "Female" genders.
Clinical Trials Status at Kaiser Permanente Washington
Currently, there are NaN active trials in "Kaiser Permanente Washington".
undefined are not yet recruiting,
18 are recruiting,
90 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 36 completed trials in Kaiser Permanente Washington,
1 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente Washington, 7 "Phase 1"
clinical trials were conducted, 66 "Phase 2" clinical
trials and 76 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 9 trials that are defined as “Not Applicable".